Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8738730 | International Journal of Antimicrobial Agents | 2018 | 30 Pages |
Abstract
The licensed regimen of caspofungin is insufficient to achieve the PK/PD targets in critically ill patients on haemodiafiltration. The determination of MICs will enable dose scheme selection.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Alejandro Pérez-Pitarch, Rafael Ferriols-Lisart, Gerardo Aguilar, Carlos Ezquer-GarÃn, F. Javier Belda, Beatriz Guglieri-López,